Our product is a software platform that makes it really easy for industrial biotechnology companies to interface with machine learning models for enzyme engineering. Enzymes power most chemical reactions in nature but usually need engineering to work at industrial scale. Our models can be used to suggest high performing sequences that would have typically taken months of wet lab work to identify.
Employees: 11-50
Investors 2
| Date | Name | Website |
| 27.08.2021 | Y Combinat... | ycombinato... |
| - | E14 Fund | e14.vc |
Mentions in press and media 1
| Date | Title | Description | Source |
| 01.09.2021 | Here are all the companies from Day 2 of Y Combinator’s Summ... | Welcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day... | techcrunch... |